Clinical Trial Update: Isoflurane at Subanesthetic Concentrations - 6 [Phase 2]

View source ↗

Summary

A Phase 2 trial tested subanesthetic isoflurane for opioid-related and other substance-related disorders. The study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders
• Substance-related Disorders

Drugs mentioned

• isoflurane (isoflurane)

Snippet

Sponsor: University of Chicago | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED